Advanced Oxygen Therapy expanded its multimodality topical wound oxygen product family with a new, larger extremity-chamber that will allow more patients with non-healing wounds to benefit.
The new chamber is specially designed to address the needs of patients with larger limbs, those with venous leg ulcers being treated by conventional compression dressings or UNNA boots, or those with diabetic foot ulcers being offloaded with a total contact cast.
TWO2 therapy has been shown to be particularly helpful in treating edematous wounds by providing cyclical-pressure oxygen to help reduce edema via noncontact compression. TWO2 treatments are applied without the need to remove gas-permeable dressings, with oxygen diffusing easily through CCD, UNNA boots and TCC adjunctive treatments.
“Prescribers had requested a larger version of our extremity-chamber, so they could treat the non-healing wounds of patients that simply could not fit into the medium-sized chamber, due to either the size of their limbs, or because they were also being treated with other adjunctive therapies, such as total contact casting and conventional compression dressings,” said Mike Griffiths, PhD, CEO and medical director of AOTI. “We are proud to be able to now provide the proven durable-healing outcomes of TWO2 to many more chronic wound patients in combination with their mainstay treatments.”
Once ordered by the prescriber, use of the topical oxygen products can be supplemented free telehealth feedback from Advanced Oxygen Therapy.